Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?-Reference-Cited by-同舟云学术

Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?

Published:2016-05-10 Issue:6 Volume:33 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Abbas Mahmoud,Steffens Sandra,Bellut Maria,Becker Jan U.,Großhennig Anika,Eggers Hendrik,Wegener Gerd,Kuczyk Markus A.,Kreipe Hans H.,Grünwald Viktor,Schrader Andres J.,Ivanyi Philipp

Funder

Deutsche Gesellschaft für Urologie

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-016-0770-8.pdf

Reference24 articles.

1. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 1992;11(11):3887–95.

2. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000;192(7):1027–34.

3. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. 2007;27(1):111–22. doi: 10.1016/j.immuni.2007.05.016 .

4. Terme M, Ullrich E, Aymeric L, Meinhardt K, Desbois M, Delahaye N, et al. IL-18 induces PD-1-dependent immunosuppression in cancer. Cancer Res. 2011;71(16):5393–9. doi: 10.1158/0008-5472.CAN-11-0993 .

5. Blank C, Gajewski TF, Mackensen A. Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy. Cancer Immunol Immunother. 2005;54(4):307–14. doi: 10.1007/s00262-004-0593-x .

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Non-Clear Cell Renal Cell Carcinoma;International Journal of Molecular Sciences;2024-03-31

2. Clinicopathologic evaluation of cd80, cd86, and pd-l1 expressions with immunohistochemical methods in malignant melanoma patients;Turkish Journal of Pathology;2023

3. Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma;Kidney Cancer;2022-03-15

4. Clinicopathological correlation and prognostic value of PD-L1 expression in renal cell carcinoma;Immunopathologia Persa;2022-02-14

5. The Prognostic Impact of PD-L2 in Papillary Renal-Cell Carcinoma;Urologia Internationalis;2022